Biopharma, Performance Materials and Life Science Segments of Merck Limited Sustainability Profile
Merck Limited, a prominent player in the biopharma, performance materials, and life sciences sectors, is headquartered in India. Established in 1668, the company has evolved significantly, marking key milestones in innovation and market expansion. With a strong presence in Asia and beyond, Merck Limited is renowned for its cutting-edge solutions in pharmaceuticals, biotechnology, and advanced materials. The company’s core offerings include biopharmaceuticals, laboratory supplies, and high-performance materials, distinguished by their commitment to quality and sustainability. Merck Limited has consistently maintained a strong market position, recognised for its contributions to scientific research and development. As a trusted partner in the life sciences industry, Merck Limited continues to drive advancements that enhance health and well-being globally.
DitchCarbon Score
How does Biopharma, Performance Materials and Life Science Segments of Merck Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biopharma, Performance Materials and Life Science Segments of Merck Limited's score of 30 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Merck Limited's Biopharma, Performance Materials, and Life Science segments currently do not report specific carbon emissions data, as no emissions figures are available. The organisation is a merged entity, inheriting its climate commitments and targets from its parent company, Merck KGaA, at a cascade level of 3. While specific reduction targets or achievements are not detailed, Merck KGaA has established science-based targets (SBTi) and participates in the Carbon Disclosure Project (CDP), indicating a commitment to transparency and accountability in climate action. These initiatives reflect a broader industry trend towards reducing greenhouse gas emissions and enhancing sustainability practices. As a merged entity, Merck Limited's performance data may also be influenced by EMD Millipore Corporation, which operates at a cascade level of 2. However, without specific emissions data or reduction targets, the focus remains on the overarching commitments inherited from its parent organisation. In summary, while detailed emissions data is currently unavailable, Merck Limited's segments are aligned with the climate initiatives of Merck KGaA, demonstrating a commitment to addressing climate change through inherited strategies and industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2006 | 2010 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 352,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | - | - | 0,000,000,000 | 000,000,000 |
| Scope 2 | 402,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | 000,000,000 | 000,000,000 |
| Scope 3 | - | 00,000,000 | - | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Biopharma, Performance Materials and Life Science Segments of Merck Limited's Industry?
How Carbon Intensive is Biopharma, Performance Materials and Life Science Segments of Merck Limited's Location?
Biopharma, Performance Materials and Life Science Segments of Merck Limited's Scope 3 Categories Breakdown
Biopharma, Performance Materials and Life Science Segments of Merck Limited's Scope 3 emissions, which decreased by 12% last year and increased significantly since 2010, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 55% of Scope 3 emissions.
Top Scope 3 Categories
Biopharma, Performance Materials and Life Science Segments of Merck Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Biopharma, Performance Materials and Life Science Segments of Merck Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
